An Exploratory Biomarker Study of ARQ 501 in Patients With Advanced Solid Tumors

Conditions

• Advanced Solid Tumors

Interventions

• DRUG: ARQ 501

Sponsor

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)